CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P116. A total of 14 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 42,993 | $28,000 | 0.00% |
| UBS Group AG | 18,613 | $12,000 | 0.00% |
| Squarepoint Ops LLC | 18,115 | $12,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 4,079 | $3,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,642 | $17,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 508,566 | $330,000 | 0.00% |
| TWO SIGMA ADVISERS, LP | 20,400 | $13,000 | 0.00% |
| Renaissance Technologies | 21,400 | $14,000 | 0.00% |